Geode Capital Management, LLC Immunovant, Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Immunovant, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,510,926 shares of IMVT stock, worth $41.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,510,926
Previous 1,414,002 6.85%
Holding current value
$41.6 Million
Previous $37.3 Million 11.35%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$27.51 - $27.51 $2.67 Million - $2.67 Million
96,924 Added 6.85%
1,510,926 $41.6 Million
Q2 2024

Aug 09, 2024
BUY
$25.1 - $31.61 $2.44 Million - $3.07 Million
97,175 Added 7.38%
1,414,002 $37.3 Million
Q1 2024

May 13, 2024
BUY
$30.27 - $43.79 $1.33 Million - $1.92 Million
43,861 Added 3.45%
1,316,827 $42.5 Million
Q4 2023

Feb 13, 2024
BUY
$31.31 - $44.19 $4.03 Million - $5.68 Million
128,632 Added 11.24%
1,272,966 $53.6 Million
Q3 2023

Nov 13, 2023
SELL
$18.55 - $39.96 $485,805 - $1.05 Million
-26,189 Reduced 2.24%
1,144,334 $43.9 Million
Q2 2023

Aug 11, 2023
BUY
$14.2 - $23.75 $1.73 Million - $2.89 Million
121,805 Added 11.61%
1,170,523 $22.2 Million
Q1 2023

May 15, 2023
BUY
$15.27 - $19.72 $689,028 - $889,825
45,123 Added 4.5%
1,048,718 $16.3 Million
Q4 2022

Feb 13, 2023
BUY
$6.59 - $17.75 $1.25 Million - $3.37 Million
189,926 Added 23.34%
1,003,595 $17.8 Million
Q3 2022

Nov 14, 2022
BUY
$3.93 - $6.37 $73,479 - $119,099
18,697 Added 2.35%
813,669 $4.54 Million
Q2 2022

Aug 12, 2022
BUY
$3.38 - $5.65 $20,732 - $34,657
6,134 Added 0.78%
794,972 $3.1 Million
Q1 2022

May 13, 2022
SELL
$5.06 - $8.77 $159,698 - $276,789
-31,561 Reduced 3.85%
788,838 $4.35 Million
Q4 2021

Feb 11, 2022
SELL
$7.33 - $9.32 $260,280 - $330,943
-35,509 Reduced 4.15%
820,399 $6.99 Million
Q3 2021

Nov 12, 2021
BUY
$7.01 - $11.37 $61,673 - $100,033
8,798 Added 1.04%
855,908 $7.44 Million
Q2 2021

Aug 13, 2021
BUY
$9.4 - $16.85 $486,826 - $872,661
51,790 Added 6.51%
847,110 $8.95 Million
Q1 2021

May 12, 2021
BUY
$13.08 - $49.6 $534,056 - $2.03 Million
40,830 Added 5.41%
795,320 $12.8 Million
Q4 2020

Feb 12, 2021
BUY
$36.36 - $52.71 $7.13 Million - $10.3 Million
196,009 Added 35.1%
754,490 $34.8 Million
Q3 2020

Nov 13, 2020
BUY
$22.61 - $38.9 $4.45 Million - $7.66 Million
196,912 Added 54.46%
558,481 $19.7 Million
Q2 2020

Aug 13, 2020
BUY
$13.87 - $28.44 $4.75 Million - $9.74 Million
342,394 Added 1785.63%
361,569 $8.8 Million
Q1 2020

May 14, 2020
BUY
$8.36 - $17.13 $160,303 - $328,467
19,175 New
19,175 $298,000

Others Institutions Holding IMVT

# of Institutions
214
Shares Held
64.3M
Call Options Held
697K
Put Options Held
629K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email